Cargando…

Combination Intensity-Modulated Radiotherapy and Sorafenib Improves Outcomes in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

PURPOSE: To compare the difference in outcome of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVTT) between intensity-modulated radiotherapy (IMRT) concurrent with sorafenib and IMRT alone. METHODS: A total of 82 patients with PVTT from 2014 to 2019 were included. Of these, 36 receive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abulimiti, Munire, Li, Zhenyu, Wang, Haifeng, Apiziaji, Palida, Abulimiti, Yisikandaer, Tan, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664501/ https://www.ncbi.nlm.nih.gov/pubmed/34899910 http://dx.doi.org/10.1155/2021/9943683

Ejemplares similares

miR-148a Regulates the Stem Cell-Like Side Populations Distribution by Affecting the Expression of ACVR1 in Esophageal Squamous Cell Carcinoma
por: Tan, Yao, et al.
Publicado: (2020)

Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib
por: Kermiche-Rahali, Sabrina, et al.
Publicado: (2013)

Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
por: Jeong, Soung Won, et al.
Publicado: (2013)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies
por: Qi, Xingshun, et al.
Publicado: (2015)

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
por: Lee, Jung Min, et al.
Publicado: (2016)

Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
por: Que, Jenny, et al.
Publicado: (2020)

Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes
por: Khorprasert, Chonlakiet, et al.
Publicado: (2021)

Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
por: Jo, Hyun Ho, et al.
Publicado: (2020)

Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma
por: Lee, Ju Hye, et al.
Publicado: (2014)

Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
por: Shui, Yongjie, et al.
Publicado: (2018)

Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?
por: Choe, Jung Wan, et al.
Publicado: (2022)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Portal Vein Thrombosis
por: Cohen, Ronny, et al.
Publicado: (2015)

Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
por: Xi, Mian, et al.
Publicado: (2013)

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2023)

Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
por: Kim, Pyeong Hwa, et al.
Publicado: (2019)

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
por: Cao, Yanyan, et al.
Publicado: (2021)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016)

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2015)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides
por: Khan, Abdul Rehman, et al.
Publicado: (2021)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
por: Kim, Sang Jin, et al.
Publicado: (2021)

Isolation and Evaluation of Bioactive Protein and Peptide from Domestic Animals’ Bone Marrow
por: Rozi, Parhat, et al.
Publicado: (2018)

Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
por: Huang, Yu-Ming, et al.
Publicado: (2022)

A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy
por: Lee, Jin Yong, et al.
Publicado: (2020)

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
por: Kim, Yong Tae, et al.
Publicado: (2023)

Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
por: Ji, Xiaoquan, et al.
Publicado: (2023)

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib
por: Kee, Kwong-Ming, et al.
Publicado: (2014)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)

Melioidosis with Portal Vein Thrombosis
por: Direksunthorn, Thanyaporn
Publicado: (2017)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv, Wei-Fu, et al.
Publicado: (2018)

Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Non-Traumatic Intramuscular Hip Hematoma in a Cirrhotic Patient With Hepatocellular Carcinoma and Portal Vein Thrombosis Treated With Sorafenib and Low Molecular Weight Heparin
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Chemoembolization Plus Radiotherapy versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis
por: Chu, Hee Ho, et al.
Publicado: (2020)

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3a2ji4gt0fmonh6qjrjeknlkoe